September 29, 2023

Bobbys Brane

Bobbys Brane – Business & Tech Blog

Danaher to buy Abcam in deal valued at $5.7 billion By Reuters

1 min read

© Reuters.

(Reuters) -Danaher Corp said on Monday it would buy medical equipment vendor Abcam Plc in a deal valued at $5.7 billion including debt, to expand its portfolio of biomedical services.

Danaher (NYSE:) will pay $24 per share in cash, a 2.7% premium to Abcam’s last closing price.

Abcam shares rose 3.9% higher on Friday after Reuters reported Danaher was in the lead to acquire the company.

Danaher, one of the world’s largest suppliers of diagnostic tools with a market value of $190 billion, has turned to dealmaking to expand in the sector. Abcam’s antibody and reagent solutions could help Danaher win more and bigger contracts with some customers.

Popular Among Readers